Groowe Groowe / Newsroom / ORIC
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ORIC News

Oric Pharmaceuticals, Inc. Common Stock

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
ORIC

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

globenewswire.com
ORIC

Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight

globenewswire.com
BIIB HRMY XNCR AZN LLY PFE REGN NVS TSLA TAK GSK JNJ UCB BHF PRAX XENE AQST TNDM INCY MRK ABBV BMY AMGN GILD VRTX CRSP EDIT NTLA SRPT ALNY EXAS TEVA AXSM CYTK INSM KODK LPCN MNKD NBIX NCLH ONCY ORIC PBYI PEGA PLRX PRGS QGEN RGNX ROST RYAAY SNOW SWKS SYK TGT TRMB TXG ULTA VRSK WDC WVE XOM ZBRA ZNTL ZTS STOK IONS MOMO BBAR CTXR MBIO GNS NEON OVID BHVN

Global Fusion Biopsy Market to Register Sustainable Growth at a CAGR of ~6% by 2034 | DelveInsight

globenewswire.com
BSX CAH MDT GEHC XRAY AMGN AZN BMY LLY MRK PFE SNY TEVA JNJ BIIB GILD NVS GOOG MSFT IBM NVDA INTC AMD QCOM AMAT MU NXPI ASML ADI LRCX KLAC CDNS SNPS MCHP ON STM MRVL AEHR TER PAYX CTAS WST ZBRA VRSN NOW CRM ADBE PANW CSCO ACN HPQ ORCL SAP PTC ALGN ESTC DDOG SMCI EXAS CRSP EDIT BEAM NTLA REGN VRTX XOM CVX SHEL BABA JD PDD NTES BIDU IQ BILI VIPS HTHT EDU TAL MELI AMZN NFLX DIS CMCSA VZ T SIRI GOOGL AAPL META TSLA GE PHI BRKR AUR FONR BFLY CRI EXEL TAK ABSI JHG XNCR MOD ARVN CLAR BNTX FOR ORIC COOK OWL MTA SKIN HYPR ALLT MAGN

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
ORIC

Form 8-K

sec.gov
ORIC

ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates

globenewswire.com
ORIC

Form 8-K

sec.gov
ORIC

ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026

globenewswire.com
ORIC

ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer

globenewswire.com
ORIC